Transplant
December 7, 2023
The Food and Drug Administration is expected to decide by Dec. 8 on a new therapy to treat sickle cell disease using gene editing technology called CRISPR,[...]
December 31, 2018
November 29, 2018
November 21, 2018
November 13, 2018
November 12, 2018
November 11, 2018
November 5, 2018
October 30, 2018
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community